Additionally, GPSMult also identifies individuals in the lower end of genetic risk who are seemingly protected from CAD with similar risk reduction as that of carriers of variants in the PCSK9 gene leading to lifelong reductions on LDL cholesterol35,36. The gene discussed is PCSK9; the disease is coronary artery disorder.